Biotinyl endothelin-1 binding to endothelin receptor and its applications

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 3, 2004, Pages 287-293

  Saravanan, K ^a   Paramasivam, M ^a   Dey, S ^a   Singh, T P ^a   Srinivasan, Alagiri ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hydroxyl apatite gel; Ligand assay; Liposomes; Membrane receptors; Pichia pastoris; Recombinant endothelin receptor A; Synthetic peptides

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; HORSERADISH PEROXIDASE; HYDROXYAPATITE; LIPOSOME; STREPTAVIDIN;

ARTICLE; BIOTINYLATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; EMBRYO DEVELOPMENT; IC 50; KIDNEY FUNCTION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; BACTERIAL PROTEINS; BINDING SITES; BINDING, COMPETITIVE; BIOTIN; BIOTINYLATION; BLOTTING, WESTERN; DURAPATITE; ENDOTHELIN-1; FORECASTING; GENE EXPRESSION; HORSERADISH PEROXIDASE; LIGANDS; PICHIA; RECEPTOR, ENDOTHELIN A;

EID: 4344564838     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000132316.24513.ec     Document Type: Article

References (29)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332: 411-415.
2. Elshourbagy NA, Korman DR, Wu HL, et al. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem. 1993;268: 3873-3879.
3. Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system. Ann Rev Physiol. 1999;61:391-415.
4. Sharifi AM, Schiffrin EL. Apoptosis in aorta of deoxycorticosterone acatate-salt hypertensive rats: effect of endothelin receptor antagonism. J Hypertension. 1997;15:1441-1448.
5. Hunley TE, Kon V. Update on endothelin-biology and clinical implications. Pediatr Nephrol. 2001;16:752-762.
6. Rubanyi GE, Polotaff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-414.
7. Clozel M. Endothelin receptor antagonists: Current status and perspectives. J Cardiovasc Pharmocol. 2000;35(Suppl 2):S65-S68.
8. Barton M, Kiowsky W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. Curr Hypertens Rep. 2001;3:322-330.
9. Nakajo S, Sugiura M, Snajdar RM, et al. Solubilization and identification of human placental endothelin receptor. Biochem Biophys Res Commun. 1989;164:205-211.
10. Buchan KW, Sumner MJ, Watts IS. Human placental membranes contain predominantly ETB receptors. J Cardiovasc Pharmacol. 1993;22(Suppl 8):S136-S139.
11. 125I endothelin-1 binding to rat and rabbit renal microvasculature. J Pharamacol Exp Ther. 1995;274: 1084-1089.
12. Harada N, Himeno A, Shigematsu K, et al. Endothelin 1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol. 2002;22:207-226.
13. Wada K, Tabuchi H, Ohba R, et al. Purification of an endothelin receptor from human placenta. Biochem Biophys Res Commun. 1990;167:251-257.
14. Villatte F, Hussain AS, Bachmann TT, et al. Expression level of heterologous protein in Pichia pastoris is influenced by flask design. Appl Microbiol Biotechnol. 2001;55:463-465.
15. Satoh M, Miyamoto C, Terashima H, et al. Human endothelin receptors ETA and ETB expressed in baculovirus-infected insect cells direct application for signal transduction analysis. Eur J Biochem. 1997;249:803-811.
16. B-selective ligands. Mol Pharmacol. 1997;52:582-589.
17. Elshourbagy NA, Korman DR, Wu HL, et al. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem. 1993;268: 3873-3879.
18. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
19. Russell FD, Davenport AP. Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139. J Cardiovasc Pharmacol. 1995;26(Suppl 3):S346-S347.
20. Shibata K, Suzawa T, Ohno T, et al. Hybrid peptides constructed from RES-701-1, an endothelin receptor antagonist and endothelin; inducing selectivity for endothelin receptors and pharmacological activity. Bioorg Med Chem. 1998;6:2459-2467.
21. Panek RL, Major TC, Hingorani GP, et al. Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem Biophys Res Commun. 1992;183:556-571.
22. Takasuka T, Horii I, Furuichi Y, et al. Detection of an endothelin 1 binding protein complex by low temperature SDS-PAGE. Biochem Biophys Res Commun. 1991;176:392-400.
23. Doi T, Sugimoto H, Arimoto I, et al. Interactions of endothelin receptor subtypes A and B with Gi, Go, and Gq in reconstituted phospholipid vesicles. Biochemistry (Mosc). 1999;38:3090-3099.
24. Carmenate T, Mesa C, Menendez T, et al. Recombinant Opc protein from Neisseria meningitides reconstituted into liposome elicits opsonic antibodies following immunization. Biotechnol Appl Biochem. 2001;34: 63-69.
25. Hashido K, Gamou K, Adachi M, et al. Truncation of N-terminal extracellular or C-terminal intracellular domains of human ETA receptor abrogated the binding activity to ET-1. Biochem Biophys Res Commun. 1992;187:1241-1248.
26. Bremnes T, Paasche JD, Mehlum A, et al. Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem. 2000;275: 17596-17604.
27. B: Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes. J Biol Chem. 1997; 272:21589-21596.
28. Magazine HI, Anderson TT, Goligorsky MS, et al. Evaluation of endothelin receptor populations using endothelin-1 biotinylated at Lysine-9 sidechain. Biochem Biophys Res Commun. 1991;181:1245-1250.
29. B receptor in endothelial cells: Receptor coupling to nitric oxide synthase. J Biol Chem. 1994;269: 21778-21785.